The Regulation of Hemostasis: The Protein C System

New England Journal of Medicine

Volumn 314, Issue 20, 1986, Pages 1298-1304

  Clouse, Lawrence H ^a,b   Comp, Philip C ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C;

BLOOD AND HEMOPOIETIC SYSTEM; HEMOSTASIS; PRIORITY JOURNAL;

EID: 0022616976     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198605153142006     Document Type: Review

References (59)

1. Best CH. The known and unknown in blood clotting and thrombosis. In: Flynn JE, ed. Blood clotting and allied problems: transaction of the first conference. New York: Josiah Macy, Jr., Foundation, 1948:26–7.
2. Mammen EF, Thomas WR, Seegers WH. Activation of purified prothrombin to autoprothrombin II (platelet cofactor II or autoprothrombin II-A). Thromb Diath Haemorrh 1960; 5: 218–49.
3. Marciniak E, Murano G, Seegers WH. Inhibitor of blood clotting derived from prothrombin. Thromb Diath Haemorrh 1967; 18: 161–6.
4. Wetmore R, Gurewich V. The role of fibrin monomer and an in vivo thrombin-induced anticoagulant in experimental venous thrombosis. Scand J Haematol 1974; 12: 204–12.
5. Stenflo J. A new vitamin K-dependent protein: purification from bovine plasma and preliminary characterization. J Biol Chem 1976; 251: 35563.
6. Seegers WH, Novoa E, Henry RL, Hassouna HI. Relationship of “new” vitamin K-dependent protein C and “old” autoprothrombin II-A. Thromb Res 1976; 8: 543–52.
7. Kisiel W, Ericsson LH, Davie EW. Proteolytic activation of protein C from bovine plasma. Biochemistry 1976; 15: 4893–900.
8. Kisiel W, Can field WM, Ericsson LH, Davie EW. Anticoagulant properties of bovine protein C following activation by thrombin. Biochemistry 1977; 16: 5824–31.
9. W., Canfield, M., Nesheim, W., Kisiel, K.G., Mann, Proteolytic inactivation of bovine factor Va by bovine activated protein C, Circulation, abstract., (1978), 58, Supplement 2, 11-210
10. Walker FJ, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979; 571: 333–42.
11. Kisiel W. Human plasma protein C: isolation, characterization, and mechanism of activation by a-thrombin. J Clin Invest 1979; 64: 761–9.
12. Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982; 59: 1067–72.
13. Miletich JP, Jackson CM, Majerus PW. Properties of the factor Xa binding site on human platelets. J Biol Chem 1977; 253: 6908–16.
14. Comp PC, Esmon CT. Activated protein C inhibits platelet prothrombin-converting activity. Blood 1979; 54: 1272–81.
15. Dahlbåck B, Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa. Eur J Biochem 1980; 107: 3315.
16. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981; 78: 2249–52.
17. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 85964.
18. Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982; 257: 7944–7.
19. Maruyama I, Salem HH, Ishii H, Majerus PW. Human thrombomodulin is not an efficient inhibitor of the procoagulant activity of thrombin. J Clin Invest 1985; 75: 987–91.
20. Salem HH, Broze GJ, Miletich JP, Majerus PW. Human coagulation factor Va is a cofactor for the activation of protein C. Proc Natl Acad Sci USA 1983; 80: 1584–8.
21. Esmon CT. Protein-C: biochemistry, physiology, and clinical implications. Blood 1983; 62: 1155–8.
22. Maruyama I, Salem HH, Majerus PW. Coagulation factor Va binds to human umbilical vein endothelial cells and accelerates protein C activation. J Clin Invest 1984; 74: 224–30.
23. Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981; 68: 1221–8.
24. Comp PC, Jacocks RM, Ferrell GL, Esmon CT. Activation of protein C in vivo. J Clin Invest 1982; 70: 127–34.
25. van Hinsbergh VWM, Bertina RM, van Wijngaarden A, van Tilburg NH, Emeis JJ, Haverkate F. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood 1985; 65: 444–51.
26. Walker FJ. Regulation of activated protein C by a new protein: a possible function for bovine protein S. J Biol Chem 1980; 255: 5521–4.
27. Di Scipio RG, Hermodson MA, Yates SG, Davie EW. A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S. Biochemistry 1977; 16: 698–706.
28. Walker FJ. Regulation of activated protein C by protein S: the role of phospholipid in factor Va inactivation. J Biol Chem 1981; 256: 11128–31.
29. Dahlbåck B, Stenflo J. High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc Natl Acad Sci USA 1981; 78: 2512–6.
30. Marlar RA, Griffin JH. Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 1980; 66: 1186–9.
31. Canfield WM, Kisiel W. Evidence of normal functional levels of activated protein C inhibitor in combined factor V/VIII deficiency disease. J Clin Invest 1982; 70: 1260–72.
32. Suzuki K. Activated protein C inhibitor. Semin Thromb Hemost 1984; 10: 154–61.
33. Gardiner JE, Griffin JH. Studies on human protein C inhibitor in normal and factor V/VIII deficient plasmas. Thromb Res 1984; 36: 197–203.
34. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor: purification from human plasma and characterization. J Biol Chem 1983; 258: 163–8.
35. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 1981; 68: 1370–3.
36. Broekmans AW, Veltkamp II, Bertina RM. Congenital protein C deficiency and venous thromboembolism: a study of three Dutch families. N Engl J Med 1983; 309: 340–4.
37. Marciniak E, Wilson HD, Marlar RA. Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. Blood 1985; 65: 15–20.
38. Branson HE, Katz J, Marble R, Griffin JH. Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 1983; 2: 1165–8.
39. Seligsohn U, Berger A, Abend M, et al. Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 1984; 310: 559–62.
40. Sills RH, Marlar RA, Montgomery RR, Deshpande GN, Humbert JR. Severe homozygous protein C deficiency. J Pediatr 1984; 105: 409–13.
41. Bertina RM, Broekmans AW. Protein C concentrates for therapeutic use. Lancet 1982; 2: 1348.
42. Mannucci PM, Viganò S. Protein C concentrates for therapeutic use. Lancet 1983; 1: 875.
43. Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann H-G. Protein C and the development of skin necrosis during anticoagulant therapy. Thromb Haemost 1983; 49: 251.
44. McGehee WG, Klotz TA, Epstein DJ, Rapaport SI. Coumarin necrosis associated with hereditary protein C deficiency. Ann Intern Med 1984; 101: 59–60.
45. Viganò S, Mannucci PM, Solinas S, Bottasso B, D'Angelo A, Mariani G. Early fall of protein C during short-term anticoagulant treatment. Thromb Haemost 1983; 50: 310. abstract.
46. Epstein DJ, Bergum PW, Bajaj SP, Rapaport SI. Radioimmunoassays for protein C and factor X: plasma antigen levels in abnormal hemostatic states. Am J Clin Pathol 1984; 82: 573–81.
47. Comp PC, Nixon RR, Esmon CT. Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood 1984; 63: 15–21.
48. J.H., Griffin, A., Bezeaud, B., Evatt, D., Mosher, Functional and immunologic studies of protein C in thromboembolic disease, Blood, abstract., (1983), 62, Supplement 1, 301a
49. Bertina RM, Broekmans AW, Krommenhoek-van Es C, van Wijngaarden A. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency. Thromb Haemost 1984; 51: 1–5.
50. Barbui T, Finazzi G, Mussoni L, et al. Hereditary dysfunctional protein C (protein C Bergamo) and thrombosis. Lancet 1984; 2: 819.
51. Griffin JH, Mosher DF, Zimmerman TS, Kleiss AJ. Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 1982; 60: 261–4.
52. Mannucci PM, Vigano S. Deficiencies of protein C, an inhibitor of blood coagulation. Lancet 1982; 2: 463–7.
53. Marlar RA, Endres-Brooks J, Miller C. Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 1985; 66: 59–63.
54. Rodeghiero F, Mannucci PM, Viganö S, et al. Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia. Blood 1984; 63: 965–9.
55. Bauer KA, Kass BL, Beeler DL, Rosenberg RD. Detection of protein C activation in humans. J Clin Invest 1984; 74: 2033–41.
56. Schwarz HP, Fischer M, Hopmeier P, Batard MA, Griffin JH. Plasma protein S deficiency in familial thrombotic disease. Blood 1984; 64: 1297–300.
57. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984; 311: 1525–8.
58. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 1984; 74: 2082–8.
59. Busch C, Owen WG. Identification in vitro of an endothelial cell surface cofactor for antithrombin III: parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium. J Clin Invest 1982; 69: 726–9.